GSCM
NVO

Greenfield Seitz Capital Management’s Novo Nordisk NVO Stock Holding History

Greenfield Seitz Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
122,792
+2,413
+2% +$104K 1.75% 19
2026
Q1 		$4.42M Buy
120,379
+20,001
+20% +$948K 1.33% 28
2025
Q4 		$5.11M Buy
100,378
+3,418
+4% +$175K 1.68% 20
2025
Q3 		$5.38M Buy
96,960
+12,948
+15% +$758K 1.73% 20
2025
Q2 		$5.8M Buy
84,012
+5,362
+7% +$365K 2.05% 16
2025
Q1 		$5.46M Buy
78,650
+3,100
+4% +$256K 2.08% 17
2024
Q4 		$6.5M Buy
75,550
+10,288
+16% +$1.11M 2.47% 11
2024
Q3 		$7.77M Sell
65,262
-1,650
-2% -$220K 2.85% 8
2024
Q2 		$9.55M Sell
66,912
-2,923
-4% -$387K 3.54% 4
2024
Q1 		$8.97M Sell
69,835
-2,688
-4% -$320K 3.34% 5
2023
Q4 		$7.5M Buy
+72,523
New +$7.17M 2.99% 6

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Greenfield Seitz Capital Management's NVO Position: Q2 2026 in Review

Greenfield Seitz Capital Management increased its Novo Nordisk (NVO) stake by 2% in Q2 2026, buying an estimated $104K and bringing the position to 122,792 shares worth $5.89M. The position accounts for 1.75% of the portfolio, ranked #19.

Greenfield Seitz Capital Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.55M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Greenfield Seitz Capital Management held 122,792 shares of Novo Nordisk worth $5.89M as of Q2 2026.
  • Greenfield Seitz Capital Management bought 2,413 Novo Nordisk shares in Q2 2026, an estimated $104K.
  • Novo Nordisk made up 1.75% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #19 holding.
  • Greenfield Seitz Capital Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Greenfield Seitz Capital Management's Novo Nordisk position peaked at $9.55M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.